Immunic(IMUX)
$7.79-0.33 (-4.06%)
IMUX
Immunic financials statements
$7.79
At close:-0.33 (-4.06%)
Want to see IMUX full AI Analyst Report?
Immunic (IMUX) Income Statement
2,277 Followers
Immunic Income Statement
Last quarter (Q3 2026), Immunic's total revenue was $0.00. In Q3, Immunic's net income was $-42.31M. See Immunic’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 103.23M | $ 98.05M | $ 99.22M | $ 119.49M | $ 91.67M | |
| Depreciation and Amortization | $ 168.00K | $ 134.00K | $ 111.00K | $ 77.00K | $ 85.00K |
| $ -97.00M | $ -100.37M | $ -93.50M | $ -86.44M | $ -92.86M | |
| $ -103.23M | $ -98.05M | $ -99.22M | $ -119.49M | $ -91.67M | |
| $ 6.06M | $ -2.46M | $ 5.61M | $ -919.00K | $ -1.28M | |
| $ -97.17M | $ -100.51M | $ -93.61M | $ -120.41M | $ -92.94M | |
| $ -97.17M | $ -100.51M | $ -93.61M | $ -120.41M | $ -92.94M | |
| Per Share Metrics | |||||
| Basic EPS | $ -6.24 | $ -10.03 | $ -21.12 | $ -37.84 | $ -39.30 |
| Diluted EPS | $ -6.24 | $ -10.03 | $ -21.12 | $ -37.84 | $ -39.30 |
| Weighted Average Shares Outstanding | 15.57M | 10.02M | 4.43M | 3.18M | 2.37M |
| Weighted Average Shares Outstanding (Diluted) | 15.57M | 10.02M | 4.43M | 3.18M | 2.37M |
Currency in USD
